STEPS IN MEDICAL EVALUATION AND TREATMENT

[Guest guest]

STEPS IN MEDICAL EVALUATION AND TREATMENT

_http://www.chemicalinjury.net/MC/2%20Steps%20in%20Medical%20Evaluation%20and%

20Treatment.doc_

(http://www.chemicalinjury.net/MC/2%20Steps%20in%20Medical%20Evaluation%20and%20\

Treatment.doc)

1. Ask about warning symptoms below: when they first started

Ø Recurrent or chronic symptoms

¨ Respiratory irritation/burning/congestion – sinus, nasal hoarseness

and/or lower respiratory

¨ GI, especially “acid reflux-likeâ€, diarrhea, abdominal pain

¨ Urinary urgency, frequency without infection

¨ Migraine

¨ Skin – hives and other unexplained rashes

¨ Aching and fatigue – these have biochemical causes and often chemical

links: calling them “syndromes†does not tell you the cause – external

factors and internal biochemical changes. See website Testing and Neural

Sensitization for more details.

Ø Ask the Patient

¨ When symptoms first started

¨ To gather information on exposure when symptoms started, and when

they got worse

¨ The patient/family/friends can go to other website locations to help

you collect information

¨ To keep an illness log for symptoms that get better and worse – see

Questionnaire.

¨ Use the medical questionnaire(s) on this website.

· Short form for patients with early, milder illness and screening

use

· Longer form (or use sections you choose) for sicker patients.

· Follow-up questionnaire for evaluating progress, new problems.

2. Do Testing for Treatable Chemical Injury

This can be done according to symptom/effect as listed on the table.

3. Treat the patient according to the lab results. Consult scientists with

the laboratory and Dr. Ziem’s papers on this website.

Ø Medical Evaluation and Treatment of Patients with Chemical Injury:

August 2001.

Ø Endocrine changes in Patients with Chronic Illness Following Chemical

Over-exposure, October 2003.

Ø See treatment suggestions under Testing for Treatable Chemical Injury.

4. If patients experience chronic or recurrent respiratory (upper

and/or lower) symptoms or chronic/recurrent migraine, they are likely to benefit

from the neural protocol. This typically improves other symptoms also over

time. Improvement of respiratory symptoms may be seen within weeks, other

symptoms may take a few months to notice improvement. Maximum improvement may

take

a few years. After this, a maintenance level may be needed.

Ø Consult Using the Neural Protocol. Because all ingredients are natural

to the body, no harm has been seen with the protocol. Avoid

concentrations/amounts that cause irritation/other symptoms: sicker patients

often need to

begin the protocol more slowly and dilute.

Ø Consult Neural Sensitization: The Medical Key to Treatment to better

understand the scientific basis of the protocol.

Ø Consult Neural Protocol Ingredients.

Ø The Sample Neural Protocol Prescription Form may be used or you can

create your own.

Ø The Reaction Factsheet can be used to help patients reduce

exacerbations. Listen to what they describe as measures that help them most and

avoid any

that exacerbate symptoms. Again, be careful to use more dilution if

irritation: lower nebulizer concentrations, fewer and lower dose in capsules.

Dr. Jim

Seymour and Dr. Bill Corristan at Key Pharmacy (800-878-1322) are

experienced with neural protocol use and can discuss the problem with you and

your

patients.

5. REDUCE EXPOSURES

Ø If occupational exposure is suspected, use the RIGHT TO KNOW (OSHA)

form to learn more about whether there are exacerbating factors.

Ø Allow your patient to use the Environmental Control Plan to involve

them in identifying exacerbating exposures.

Ø More seriously affected patients may need/want to use a mask for

certain exposures: consult Use of the DenBrader Mask.

Two studies Lax, MB, Henneberger PK. 1995. Arch Environ Health, 50(6):

425-31 and DePaul University: Leroy, J., David, T. H., and Jason, L. A. CFIDS

Chronicles, 9:52-53, 1996) show that reducing exposure of chemically injured

patients reduces adverse health affects. This is consistent with the basic

dictum of all toxicology: that reducing the exposure dose reduces adverse health

effects (Casarett and Doull’s Toxicology: The Basic Science of Poisons,

edited

by C. D. Klassen etal. Macmillan, New York 2001.) This is because chemically

injured patients often have damaged brain function, also know as toxic

encephalopathy, immune abnormalities and disturbances of porphyrin metabolism

(G.E. Ziem, Environmental Health Perspectives, 1999) and petrochemical exposure

is known to exacerbate encephalopathy and porphyrin disturbance. Chemically

injured patients also have impaired detoxification usually involving reduced

function of one or more Phase II steps (G. Ziem, J. McTamney, “Profile of

Patients with Chemical Injury and Sensitivityâ€, Environ Health Persp, 105

(2):

417-436, 1997.

 

 

 

**************